drugset / Trial / NCT02175394
Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective was to investigate the effect of multiple oral doses of 5 mg BI 1356 on the steady-state pharmacokinetics of ethinylestradiol (EE) and levonorgestrel (LNG), the components of Microgynon®
Timeline
- Start
- 2008-07
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | — |
| Subject | Linagliptin | Unknown | 5 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | — | — |
Indications
No indication recorded.